Targeting TOR dependence in cancer
- Author(s): Janes, MR
- Fruman, DA
- et al.
Published Web Locationhttps://doi.org/10.18632/oncotarget.110
© 2010 Janes et al. A challenge in cancer therapy has been to identify targets whose function is essential for survival of malignant cells but not normal cells. This Perspective discusses recent evidence that novel inhibitors of the kinase TOR can provide an unprecedented balance of anti-cancer efficacy and tolerability.
Many UC-authored scholarly publications are freely available on this site because of the UC Academic Senate's Open Access Policy. Let us know how this access is important for you.